Navigation Links
MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
Date:2/14/2008

GERMANTOWN, Md., Feb. 14 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that it has engaged Morgan Stanley as its strategic advisor in connection with the Company's ongoing process to explore strategic alternatives.

As previously announced, in 2007, MiddleBrook's board of directors authorized the Company to evaluate various strategic alternatives to further enhance shareholder value. Since that time, MiddleBrook has been involved in the process of evaluating a full range of strategic alternatives available to the Company. Pacific Growth Equities, LLC will act as co-advisor with Morgan Stanley in MiddleBrook's ongoing strategic process.

Strategic alternatives the Company may pursue could include, but are not limited to, continued execution of the Company's operating plan, the sale of Company assets, partnering or other collaboration agreements, or a merger, sale of the Company or other strategic transaction. There can be no assurance that the exploration of strategic alternatives will result in any agreements or transactions, or that, if completed, any agreements or transactions will be successful or on attractive terms. The Company does not intend to disclose developments with respect to this process unless and until the evaluation of strategic alternatives has been completed.

ABOUT MIDDLEBROOK PHARMACEUTICALS:

MiddleBrook Pharmaceuticals, Inc. (Nasdaq:
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
3. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... (PRWEB) September 03, 2014 Recently, BambooIndustry.com, ... its new range of strand woven bamboo floors ... more clients and show its appreciation to the frequent ... products. , In addition to strand woven floors, ... clients, including hand scraped floors, click strand woven floors, ...
(Date:9/2/2014)... Atlanta, Ga. (PRWEB) September 02, 2014 ... hosted by, respectively, top-industry professionals Carey Lewis ... each person auditioning, seeking those who have the desire ... chosen for a callback, performers could be invited to ... SHINE convention. , Charlotte, NC – Saturday, Sept. 6, ...
(Date:9/2/2014)... 2014 The Wm. Jennings Bryan Dorn Veterans ... town hall meeting for Veterans and their families on September ... fair to provide Veterans with valuable healthcare and benefit information,” ... will provide a forum where we can gather important input ... outreach fair will be held 4:45 p.m. to 5:45 p.m. ...
(Date:9/2/2014)... In a large population-based study of randomly selected ... impairment (MCI) occurred twice more often in individuals ... strong association was only observed in middle-aged participants ... the association vanished. This study is published in ... The concept of MCI describes an intermediate state ...
(Date:9/2/2014)... Operators in the Community Services industry ... care and counsel for those in need. In 2014-15, ... derive $39.4 billion in revenue, which includes a combination ... five years through 2014-15, the subdivision is forecast to ... of 4.1% in 2014-15. , As the population ages ...
Breaking Medicine News(10 mins):Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2Health News:Diabetes mellitus and mild cognitive impairment: Higher risk in middle age? 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3
... Using tiny gold particles embedded with dyes, researchers have ... of a living animal. These tools may allow doctors ... , Studded with antibody fragments called ScFv peptides that ... after their injection into a mouse. When illuminated with ...
... simple steps can help you cope , , SATURDAY, Dec. 22 ... of joy and celebration for many, it can trigger holiday ... to holiday blues, there are things you can do to ... Mood Disorders Program at the Jefferson Medical College of Thomas ...
... Kansas Hospital Offers Tips to Guard Against Influenza as ... ... While it may be too late to,purchase certain must-have gifts ... shot. The World Health Organization (WHO) and,National Respiratory and Enteric Virus ...
... PCYC ) today announced that it has received a ... for the company,s,new drug application (NDA) for Xcytrin(R) (motexafin ... (NSCLC) patients with brain,metastases. The NDA for use of ... filed with the FDA in April 2007., According ...
... indications than any other ... drug-eluting stent, ... announced today that its TAXUS(R) Liberte(TM),paclitaxel-eluting coronary stent system has received ... submitted,data showing the TAXUS Liberte stent has benefited diabetic patients with,coronary ...
... considered, protected, HARRISBURG, Pa., Dec. 21 To ... Joel,Ario today announced that the Insurance Department will hold ... the proposed consolidation of,Independence Blue Cross and Highmark Inc., ... would be protected in,any transaction of this type, so ...
Cached Medicine News:Health News:Gold nanoparticle probes may allow earlier cancer detection 2Health News:Gold nanoparticle probes may allow earlier cancer detection 3Health News:Maintaining Routine Can Chase Holiday Blues Away 2Health News:Attention Last-Minute Shoppers: Flu Shots Still Available 2Health News:Attention Last-Minute Shoppers: Flu Shots Still Available 3Health News:Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases 2Health News:Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases 3Health News:TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients 2Health News:TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients 3Health News:TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients 4Health News:TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients 5Health News:Insurance Department Will Hold Public Hearings on Proposed Consolidation of Highmark, Independence Blue Cross 2
(Date:9/2/2014)... 2, 2014 According to the ... Pre-packed, Analytical, Preparative), by Material (Metal, Glass, Plastic), by ... Forecast to 2018", published by MarketsandMarkets, the Chiral Chromatography ... is poised to grow at a CAGR of 5.2% ... Browse 90 market data tables and 15 ...
(Date:9/2/2014)... ALISO VIEJO, Calif. , Sept. 2, 2014  Avanir ... company management will present an overview of the company at ... York . , Presentation date: Tuesday September ... A live webcast and 30-day archive of ... About Avanir Pharmaceuticals, Inc. Avanir Pharmaceuticals, ...
(Date:9/2/2014)... 2014  EMD Serono, Inc., a subsidiary of Merck ... that Drew Young has joined the company ... capacity, he will be responsible for leading the strategic ... future products.   Bringing more than 20 years ... efforts at pharmaceutical and biotech companies, Mr. Young comes ...
Breaking Medicine Technology:Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 3EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 4
... Chrome-plated metal frames ... ensures optimal cleanliness and ... stools come with user-friendly ... height adjustment. Fixed footring ...
... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
Inquire...
Medicine Products: